a 2018

CD20 is a direct regulator of B-cell receptor signaling in the microenvironment of chronic lymphocytic leukemia

PAVLASOVÁ, Gabriela, Veronika SVOBODOVÁ, Marek BORSKÝ, Jan OPPELT, J. NOVOTNÁ et. al.

Basic information

Original name

CD20 is a direct regulator of B-cell receptor signaling in the microenvironment of chronic lymphocytic leukemia

Authors

PAVLASOVÁ, Gabriela (203 Czech Republic, belonging to the institution), Veronika SVOBODOVÁ (203 Czech Republic), Marek BORSKÝ (203 Czech Republic, belonging to the institution), Jan OPPELT (203 Czech Republic, belonging to the institution), J. NOVOTNÁ (203 Czech Republic), Kateřina AMRUZ ČERNÁ (203 Czech Republic, belonging to the institution), Kateřina MUSILOVÁ (203 Czech Republic, belonging to the institution), Václav ŠEDA (203 Czech Republic, belonging to the institution), Yvona BRYCHTOVÁ (203 Czech Republic, belonging to the institution), Michael DOUBEK (203 Czech Republic, belonging to the institution), Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution), Jiří MAYER (203 Czech Republic, belonging to the institution) and Marek MRÁZ (203 Czech Republic, guarantor, belonging to the institution)

Edition

2018

Other information

Language

English

Type of outcome

Conference abstract

Field of Study

10606 Microbiology

Confidentiality degree

is not subject to a state or trade secret

RIV identification code

RIV/00216224:14740/18:00104060

Organization unit

Central European Institute of Technology

Keywords in English

CD20; receptor; microenvironment; CLL

Tags

Changed: 26/3/2019 15:26, Mgr. Pavla Foltynová, Ph.D.

Abstract

V originále

CD20 is a direct regulator of B-cell receptor signaling in the microenvironment of chronic lymphocytic leukemia, CD20 is a direct regulator of B-cell receptor signaling in the microenvironment of chronic lymphocytic leukemia.

Links

LQ1601, research and development project
Name: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/0968/2017, interní kód MU
Name: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit V (Acronym: VýDiTeHeMA V)
Investor: Masaryk University, Category A
MUNI/H/0865/2016, interní kód MU
Name: Coding and Non-coding RNA Networks that Regulate B Cell Receptor Signalling: Implications for Combinatorial Therapy
Investor: Masaryk University, Individual High risk/high gain projects
NV16-29622A, research and development project
Name: VLIV TERAPEUTICKÉ INHIBICE BCR SIGNALIZACE NA GENOVOU EXPRESI U B BUNĚČNÝCH MALIGNIT A JEJÍ PROGNOSTICKÝ A PREDIKTIVNÍ VÝZNAM
692298, interní kód MU
Name: MEDGENET - Medical genomics and epigenomics network (Acronym: MEDGENET)
Investor: European Union, Spreading excellence and widening participation